1. Home
  2. LEGN vs FAF Comparison

LEGN vs FAF Comparison

Compare LEGN & FAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • FAF
  • Stock Information
  • Founded
  • LEGN 2014
  • FAF 1889
  • Country
  • LEGN United States
  • FAF United States
  • Employees
  • LEGN N/A
  • FAF N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • FAF Specialty Insurers
  • Sector
  • LEGN Health Care
  • FAF Finance
  • Exchange
  • LEGN Nasdaq
  • FAF Nasdaq
  • Market Cap
  • LEGN 5.4B
  • FAF 6.1B
  • IPO Year
  • LEGN 2020
  • FAF N/A
  • Fundamental
  • Price
  • LEGN $35.56
  • FAF $66.48
  • Analyst Decision
  • LEGN Strong Buy
  • FAF Buy
  • Analyst Count
  • LEGN 10
  • FAF 4
  • Target Price
  • LEGN $73.67
  • FAF $75.00
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • FAF 650.2K
  • Earning Date
  • LEGN 08-11-2025
  • FAF 07-23-2025
  • Dividend Yield
  • LEGN N/A
  • FAF 3.34%
  • EPS Growth
  • LEGN N/A
  • FAF N/A
  • EPS
  • LEGN N/A
  • FAF 1.82
  • Revenue
  • LEGN $796,838,000.00
  • FAF $6,514,800,000.00
  • Revenue This Year
  • LEGN $66.76
  • FAF $17.05
  • Revenue Next Year
  • LEGN $52.58
  • FAF $9.20
  • P/E Ratio
  • LEGN N/A
  • FAF $35.61
  • Revenue Growth
  • LEGN 74.75
  • FAF 9.54
  • 52 Week Low
  • LEGN $27.34
  • FAF $53.09
  • 52 Week High
  • LEGN $59.62
  • FAF $70.92
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 35.54
  • FAF 69.24
  • Support Level
  • LEGN $35.10
  • FAF $64.18
  • Resistance Level
  • LEGN $38.35
  • FAF $65.27
  • Average True Range (ATR)
  • LEGN 1.31
  • FAF 1.11
  • MACD
  • LEGN -0.37
  • FAF 0.15
  • Stochastic Oscillator
  • LEGN 11.33
  • FAF 89.70

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About FAF First American Corporation (New)

First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.

Share on Social Networks: